article thumbnail

World's largest proteomics trial launched by UK Biobank

pharmaphorum

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today.

article thumbnail

When You Got Your Period May Impact Dementia Risk, Study Finds

AuroBlog - Aurous Healthcare Clinical Trials blog

The analysis included health information from 273,260 female participants in the United Kingdom Biobank, and the findings suggest that those who start their period younger and go […]

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Alnylam finds belly fat gene and drug target in UK Biobank study

pharmaphorum

The American Heart Association issued a statement last year highlighting the risks of visceral and abdominal fat (VAT), calling for clinical trials of therapies to reduce it, as well as greater efforts to encourage patients to exercise and improve their diets. Image by Bruno /Germany from Pixabay .

article thumbnail

University of Melbourne reveals design of new infectious disease institute

Pharmaceutical Technology

The new AIID building will include a human infection challenge unit, high-containment facilities, a robotic biobanking facility, interview rooms, dry laboratories and spaces for community engagement and co-design work. It will be connected across multiple levels to the University of Melbourne’s Doherty Institute.

article thumbnail

Biorepositories as a Guiding Resource for Research & Drug Discovery

XTalks

Biobanks are used for the coordination of high-yield patient sample collection. Moreover, biobanks are no longer passive biorepositories for accrual of samples and serve a more utilitarian function in identifying and coordinating specific research cohorts for longitudinal and prospective studies. Biobanking Models.

article thumbnail

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

Pharmaceutical companies and biotechs are also adapting their approaches, launching patient finding and engagement programmes that can start years before clinical trials begin and allow them to run ‘recontact by genotype’ studies that the Resilience Project would have liked to do. Giving participants something in return.

article thumbnail

Overcoming the Challenges of Sample Tracking in Clinical Trials with Blockchain Technology

Crucial Data Soutions

It’s 2021 and sharpies are still being used to write on bio sample tubes in most clinical trials…. As most people would agree, one core tenant of a well-run clinical trial is accurately collecting, handling and analyzing bio samples from subjects during the study. Without this, results of the trial could be severely tainted.